Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Esclama
2. K 1900
3. K-1900
4. K1900
5. Naxogin
6. Nitrimidazine
7. Nulogyl
1. 6506-37-2
2. Naxogin
3. Nitrimidazine
4. Nimorazol
5. Nulogyl
6. Esclama
7. Naxofem
8. 4-(2-(5-nitro-1h-imidazol-1-yl)ethyl)morpholine
9. Acterol
10. Acterol Forte
11. 4-[2-(5-nitroimidazol-1-yl)ethyl]morpholine
12. Nimorazolo
13. Sirledi
14. K-1900
15. N-2-morpholinoethyl-5-nitroimidazole
16. 1-(2-n-morpholinylethyl)-5-nitroimidazole
17. Morpholine, 4-[2-(5-nitro-1h-imidazol-1-yl)ethyl]-
18. Nsc 107524
19. 4-(2-(5-nitroimidazol-1-yl)ethyl)morpholine
20. Nsc-107524
21. 4-[2-(5-nitro-1h-imidazol-1-yl)ethyl]morpholine
22. Morpholine, 4-(2-(5-nitro-1h-imidazol-1-yl)ethyl)-
23. Mls002703984
24. 469ulx0h4g
25. Morpholine, 4-(2-(5-nitroimidazol-1-yl)ethyl)-
26. Nimorazole (inn)
27. Nimorazolum
28. Nimorazole [inn]
29. 1-(.beta.-morpholinoethyl)-5-nitroimidazole
30. Morpholine, 4-[2-(5-nitroimidazol-1-yl)ethyl]-
31. Nimorazolo [dcit]
32. Nimorazol [inn-spanish]
33. Nimorazolum [inn-latin]
34. K 1900
35. 1-(beta-morpholinoethyl)-5-nitroimidazole
36. 1-(n-p-ethylmorpholine)-5-nitroimidazole
37. Nimorazole [inn:ban]
38. Einecs 229-394-4
39. 4-(2-(5-nitroimidazol-1-yl)ethyl)-morpholine
40. Brn 0533758
41. Unii-469ulx0h4g
42. Naxogin (tn)
43. Nimorazole [mi]
44. Nimorazole [mart.]
45. Dsstox_cid_31584
46. Dsstox_rid_97468
47. Nimorazole [who-dd]
48. Dsstox_gsid_57795
49. Schembl21836
50. Chembl435966
51. Dtxsid1057795
52. Chebi:134929
53. Bcp11055
54. Tox21_113897
55. Mfcd00866796
56. Nsc107524
57. S6411
58. Zinc26167988
59. Akos022174968
60. Db12172
61. Ncgc00261977-01
62. Ac-35227
63. Am807557
64. As-31120
65. Da-21636
66. Hy-16349
67. Smr001570693
68. Cas-6506-37-2
69. Wln: T6n Dotj A2- At5n Cnj Enw
70. Ft-0710009
71. A13091
72. D07352
73. 506n372
74. A834961
75. Q7037737
76. 4-[2-(5-nitro-1h-imidazol-1-yl)ethyl]morpholine #
| Molecular Weight | 226.23 g/mol |
|---|---|
| Molecular Formula | C9H14N4O3 |
| XLogP3 | -0.4 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 3 |
| Exact Mass | 226.10659032 g/mol |
| Monoisotopic Mass | 226.10659032 g/mol |
| Topological Polar Surface Area | 76.1 Ų |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 239 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antitrichomonal Agents
Agents used to treat trichomonas infections. (See all compounds classified as Antitrichomonal Agents.)
P - Antiparasitic products, insecticides and repellents
P01 - Antiprotozoals
P01A - Agents against amoebiasis and other protozoal diseases
P01AB - Nitroimidazole derivatives
P01AB06 - Nimorazole
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Nimorazole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nimorazole, including repackagers and relabelers. The FDA regulates Nimorazole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nimorazole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Nimorazole manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Nimorazole supplier is an individual or a company that provides Nimorazole active pharmaceutical ingredient (API) or Nimorazole finished formulations upon request. The Nimorazole suppliers may include Nimorazole API manufacturers, exporters, distributors and traders.
click here to find a list of Nimorazole suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Nimorazole DMF (Drug Master File) is a document detailing the whole manufacturing process of Nimorazole active pharmaceutical ingredient (API) in detail. Different forms of Nimorazole DMFs exist exist since differing nations have different regulations, such as Nimorazole USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Nimorazole DMF submitted to regulatory agencies in the US is known as a USDMF. Nimorazole USDMF includes data on Nimorazole's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Nimorazole USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Nimorazole suppliers with USDMF on PharmaCompass.
A Nimorazole written confirmation (Nimorazole WC) is an official document issued by a regulatory agency to a Nimorazole manufacturer, verifying that the manufacturing facility of a Nimorazole active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Nimorazole APIs or Nimorazole finished pharmaceutical products to another nation, regulatory agencies frequently require a Nimorazole WC (written confirmation) as part of the regulatory process.
click here to find a list of Nimorazole suppliers with Written Confirmation (WC) on PharmaCompass.
Nimorazole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nimorazole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nimorazole GMP manufacturer or Nimorazole GMP API supplier for your needs.
A Nimorazole CoA (Certificate of Analysis) is a formal document that attests to Nimorazole's compliance with Nimorazole specifications and serves as a tool for batch-level quality control.
Nimorazole CoA mostly includes findings from lab analyses of a specific batch. For each Nimorazole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nimorazole may be tested according to a variety of international standards, such as European Pharmacopoeia (Nimorazole EP), Nimorazole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nimorazole USP).
LOOKING FOR A SUPPLIER?
